Accelrys Posts 12 Percent Revenue Gain for Q3 | GenomeWeb

NEW YORK (GenomeWeb News) – Accelrys reported after the close of the market yesterday a 12 percent increase year over year for its third quarter.

The San Diego-based life sciences informatics firm reported GAAP revenues of $40.5 million for the three months ended Sept. 30, compared to $36.3 million for the third quarter of 2011.

Its non-GAAP revenue, which includes a deferred revenue fair value adjustment related to its merger with Symyx and acquisitions of Contur and VelQuest, was $43.4 million versus 38 million, a 14 percent increase.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.